Course Directors & Committee. UAE Organizing Committee

Course Directors & Committee UAE Organizing Committee 1 2 Course Directors & Committee Course Directors Katherine Hoercher,R.N., FAHA Sr. Dire...
Author: Duane Porter
32 downloads 2 Views 10MB Size
Course Directors & Committee

UAE Organizing Committee

1

2

Course Directors & Committee

Course Directors

Katherine Hoercher,R.N., FAHA Sr. Director Special Programs Kaufman Center for Heart Failure Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Walid Saliba, MD Director, Atrial fibrillation Center Associate Director, Cardiac Pacing and Electrophysiology Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Joseph Maalouf, MD Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Director, Interventional Echocardiography Mayo Clini , Rochester, Minnesota

US Organizing Committee

Naser Ammash, MD Professor of Medicine, Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Vice Chair, Clinical Practice, Division of Cardiovascular Diseases Mayo Clinic, Rochester, Minnesota

Wael Jaber, MD Director of Cardiac Imaging Core Lab and Center for Advanced Ischemic Heart Disease, Department of Cardiovascular Medicine Section of Cardiovascular Imaging, Heart and Vascular Institute Cleveland Clinic, Ohio, USA

www.CVUAE.com

3

Course Directors & Committee

UAE Organizing Committee

Obaid AlJassim, MD Cardiology & Cardiothoracic Surgery Centre Dubai Hospital, Dubai, United Arab Emirates

Alawi Alsheikh-Ali, MD President, Emirates Cardiac Society

Fahad Omar Ahmed S. Baslaib, MD Consultant Cardiologist and Head of Cardiology Unit Rashid Hospital,Dubai Health Authority Dubai, United Arab Emirates

Nooshin Mohd Bazargani, MD Board member of Emirates Cardiac Society Board member of World Heart Federation Consultant Cardiologist ,Dubai Hospital Deputy Head of Dubai Heart Center, Dubai, United Arab Emirates

Wael Adbulrahman Al Mahmeed, MD Board member of Emirates Cardiac Society Consultant Cardiologist, Cleveland Clinic Abu Dhabi Abu Dhabi, United Arab Emirates

CME & USEFUL INFORMATION CME Accreditation:

Regulations:

− This Conference is CME accredited with 14 CME Credits from The UAE UNIVERSITY. − Please scan your badge every time you enter to the conference Hall. − CME Certificates will be obtained starting October 25th, 2015, through the Conference website: www.cvuae.com − Delegates should log in using the registration number on their badge, fill the evaluation form and you will be able to download your certificate. − The deadline to receive your Certificates is December 24th, 2015.

Please keep your mobile phones on silent mode while in the conference rooms.

Parking: Complimentary parking is available at the venue.

Conference Secretariat: InfoPlus Events LLC - P.O. Box 71108 Dubai, United Arab Emirates Phone: +971 (0) 4 4218996 Fax: +971 (0) 4 4218838 Email: [email protected]

Food & Beverage: Coffee breaks will be open to registered delegates. Meals will be offered against daily vouchers provided with the delegate badges.

Mr. Ahmed Hajeer Project Manager InfoPlus Events Dubai, UAE [email protected]

4

www.CVUAE.com

Mr. Umair Khan Faculty Management InfoPlus Events Dubai, UAE [email protected]

Accounts Management InfoPlus Events Dubai, UAE [email protected]

Course Directors &ACommittee AGEND

Thursday, October 8, 2015 8:00-9:00

Registration and Breakfast

9:00-9:10

Opening Remarks Session I: Controversies and Challenges in the Management of Cardiovascular Diseases: Focus on Diagnosis and Management of Coronary Artery Disease

Panel: Rakesh Suri, Tomislav Mihaljevic, Feridon Noohi, Wael Jaber, Haitham Amin 9:10-9:30 9:30-9:508 9:50-10:10

Patient with multivessel disease and LV dysfunction y/o man with diabetes and negative nuclear stress test 57 y/o with planned CABG has LBBB and EF 38%

10:10-10:40

BREAK AND REFRESHMENTS

Joseph Sabik, M.D. Amy Pollack, M.D. Venu Menon, M.D.

Session II: Controversies and Challenges in the Management of Cardiovascular Disease: Focus on Antiplatelets and Anticoagulants

Panel: Walid Saliba, Oussama Wazni, Nasser Ammash, Seema Nour, Adel Khalifa 10:40-11:00 11:00-11:20 11:20-11:40 11:40-12:00

75 year old female with PCI to LAD – duration of DAPT – what is the right answer in 2015 Patient with AFib and LA clot POST STEMI and antiplatelet choice Patient with fever post WATCHMAN

12:00-13:00

LUNCH

13:00-13:45

SYMPOSIUM STATIN INTOLERANCE – HOW TO TREAT

Leslie Cho, M.D. Walid Saliba, M.D. Peter Pollack, M.D. Oussama Wazni, M.D.

Leslie Cho, M.D.

Session III: Controversies and Challenges in the Management of Cardiovascular Diseases: Focus on Novel Structural Heart Disease Interventions, Patient Selection, and Outcomes

Panel: Tomislav Mihaljevic, Rakesh Suri, Hussein Ismaeel, Fahad Baslaib, Murat Tuzcu, Abdulmajeed Al Zubaidi, Arif Al-Mulla, Wael Jaber 13:45-14:05 14:05-14:25 14:25-14:45 14:45- 15:05

86 y/o male with AS and Dyspnea Patient with severe MR: Surgery versus MitraClip Mitral peri-prosthertic Leak Patient with severe AR and LV dysfunction, Surgery or TAVR?

15:05-15:20

BREAK AND REFRESHMENTS

Joseph Maalouf, M.D. Murat Tuzcu, M.D. Peter Pollack, M.D. Venu Menon, M.D.

Session IV: Controversies and Challenges in the Management of Cardiovascular Disease: Focus on complications and outcomes following TAVR , Valve-in-Valve implantation and MitraClip

Panel: Venu Menon, Joseph Sabik, Rakesh Suri, Tomislav Mihaljevic, Fahad Baslaib, Murat Tuzcu 15:20-15:40 15:40-16:00 16:00-16:20 16:20-16:40

6

Female with mitral regurgitation who had a mitral clip Post TAVR heart Failure 68y/o female with severe TR Patient Being Considered for TAVR with LBBB

www.CVUAE.com

Joseph Maalouf, M.D. Wael Jaber, M.D. Joseph Maalouf, M.D. Oussama Wazni, M.D.

Course Directors AGEND&ACommittee

Friday, October 9, 2015 8:00-8:40

Registration and Breakfast Session V: Controversies and Challenges in the Management of Cardiovascular Diseases: Focus on Team Based Management of Heart Failure

Panel: Nooshin Bazargani, Kathy Hoercher, Sudhir Kushwaha, Hadi Skouri, Feras Bader 8:40-9:00 9:00-9:20 9:20-9:40 9:40-10:00 10:00-10:20

46 y/o male with dilated CMP and repeated hospital admissions 72 y/o male presents to ED with new symptoms of SOB, JVD, and peripheral edema 68 year old female with CAD and volume overload Update on a case from last year, HCM with heart failure

Sudhir Kuchwaha, M.D. Venu Menon, M.D. Leslie Cho, M.D. Sudhir Kuchwaha, M.D.

BREAK AND REFRESHMENTS Session V: Controversies and Challenges in the Management of Cardiovascular Diseases: Focus on EP and Pacemakers/ICD

Panel: Walid Saliba, Oussama Wazni, Nasser Ammash, Peter Pollak , Salem Al Kaabi, Mohamad Al-Mehairi 10:20-10:40 40 y/o with VT, TOF repair 10:40-11:00 45 y/o male presenting with frequent PVCS (complicated ablation) 11:00-11:45

SYMPOSIUM: CHALLENGES IN CHRONIC HEART FAILURE: THE MYTH OF THE STABLE PATIENT John McMurray, M.D.

11:45-12:30

Friday Prayer

12:30-13:10

LUNCH

Naser Ammash, M.D. Walid Saliba, M.D.

Session VII: Challenges in Management of Cardiovascular Diseases: Focus on Vascular Disease (Carotid and Peripheral)

Panel: Joseph Sabik, Robert McBane, Peter Pollak, Abdulrahman Al-Balooshi, Omar Hallak, Abdulla Shahab 13:30-13:50 17 year old girl with claudication 13:50-14:10 Asymptomatic carotid disease being evaluated for CABG 14:10-14:30 Case of low platelets

Leslie Cho, M.D. Joseph Sabik, M.D. Robert McBane, M.D.

14:30-15:15

SYMPOSIUM: NEW DEVELOPMENTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION Walid Saliba,M.D. - Oussama Wazni, M.D. - Wael Jaber, M.D.

15:15-15:30

BREAK AND REFRESHMENTS Session VIII: Controversies and Challenges in the Management of Cardiovascular Diseases: Focus on Mitral and Tricuspid Valves

Panel: Rakesh Suri, Joseph Sabik, Hussein Ismaeel, Ghazi Radaideh, Safaa Almohada, Murat Tuzcu 15:30-15:50 15:50-16:10 16:10-16:30 16:30-16:50

Post MV repair with LA mass Ebstein case with WPW Pacemaker lead extraction with acute TR 45 y/o lady with Mitral stenosis and Afib

Venu Menon, M.D. Naser Ammash, M.D. Oussama Wazni, M.D. Wael Jaber, M.D.

www.CVUAE.com

7

AGENDA

Saturday, October 10, 2015 8:00-9:00

Registration and Breakfast Session IX: Controversies and Challenges in Management of Cardiovascular Diseases: Focus on Congenital Disease

Panel: Nasser Ammash, Ahmed Omran, Wael Jaber, Haitham Ali Ridha AL Hashimi, Mohamed Khan 9:00-9:20 9:20-9:40 9:40-10:00

Congenitally Corrected Transposition with Dyspnea Young Physician With Unexplained Chest Pain Young Pregnant Woman With Enlarging Neck Mass

10:00-10:20

BREAK AND REFRESHMENTS

Naser Ammash, M.D. Wael Jaber, M.D. Naser Ammash, M.D.

Session X: Controversies and Challenges in Management of Cardiovascular Diseases: Potpourri

Panel: Venu Menon, Joseph Sabik, Joseph Maalouf, Wael Jaber, Leslie Cho, Hani Najm 10:20-10:40 10:40-11:00 11:00-11:20 11:20-11:40

Aortic Bioprosthetic Thrombosis 65 y/o with AVR and New Fever 44 year old male with DM turned down for surgery with severe 3V CAD Patient with ASD and infected pacer wire

Joseph Maalouf, M.D. Wael Jaber, M.D. Leslie Cho, M.D. Joseph Maalouf, M.D.

Adjourn

FOLLOW US ON:

http://on.fb.me/1EcDzz3

NOTES

8

www.CVUAE.com

http://bit.ly/1I4emSh

http://bit.ly/1Joyhw2

Faculty Profile

Mayo Clinic Faculty

Naser Ammash, MD Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Vice Chair, Clinical Practice, Division of Cardiovascular Diseases Mayo Clinic, Rochester, Minnesota

Sudhir Kushwaha, MD Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Medical Director, Cardiac Transplant and LVAD Program Mayo Clinic, Rochester-Minnesota

Joseph Maalouf, MD Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Director, Interventional Echocardiography Mayo Clinic, Rochester, Minnesota

Robert McBane, MD Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Chair, Vascular Medicine Section Mayo Clinic, Rochester, Minnesota

Amy Pollack, MD Assistant Professor of Medicine Mayo Clinic College of Medicine Consultant, Cardiovascular Diseases and Internal Medicine Mayo Clinic, Jacksonville, Florida

Peter Pollack, MD Senior Associate Consultant, Invasive and Interventional Cardiology Mayo Clinic, Jacksonville, Florida

www.CVUAE.com

9

Faculty Profile

Cleveland Clinic Faculty

Leslie Cho, MD Director Cleveland Clinic's Women's Cardivoascular Center Section Head, Preventive Cardiology and Rehabilitation Department of Cardiovascular Medicine Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Venu Menon, MD Cardiovascular Imaging Department of Cardiovascular Medicine Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Walid Saliba, MD Director, Atrial fibrillation Center Associate Director, Cardiac Pacing and Electrophysiology Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Oussama Wazni, MD Director. Outpatient Electrophysiology Department Co-Director Ventricular Arrhythmia Center Department of Cardiovascular Medicine Heart and Vascular Institute Cleveland Clinic, Ohio – USA

10 www.CVUAE.com

Joseph Sabik, MD Chairman & Professor of Thoracic Cardiovascular Surgery Sheikh Hamdan Bin Rashid Al Maktoum Distinguished Chair in Thoracic & Cardiovascular Surgery Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Katherine Hoercher,R.N., FAHA Sr. Director Special Programs Kaufman Center for Heart Failure Heart and Vascular Institute Cleveland Clinic, Ohi, USA

Wael Jaber, MD Director of Cardiac Imaging Core Lab and Center for Advanced Ischemic Heart Disease Department of Cardiovascular Medicine Section of Cardiovascular Imaging Heart and Vascular Institute Cleveland Clinic, Ohio, USA

Faculty Profile

Cleveland Clinic Abu-Dhabi Faculty

Murat Tuzcu, M.D. Chief Academic Officer Abu-Dhabi - UAE

Tomislav Mihaljevic, M.D. Chief of Staff Abu-Dhabi - UAE

Rakesh Suri, M.D. Chief of Medical Operations Abu-Dhabi – UAE

Wael Al Mahmeed, M.D. Staff Physician Abu-Dhabi - UAE

Invited Local & Regional Faculty Abdulrahman Al Balooshi, M.D Abu Dhabi - UAE

Haitham Amin, M.D. Manama - Bahrain

Feridon Noohi, M.D. Tehran - Iran

Haitham Ali Ridha Al Hashimi, M.D. Dubai - UAE

Abdulmajeed Al Zubaidi, M.D. Abu Dhabi - UAE

Seema Nour, M.D. Abu Dhabi - UAE

Obaid AlJassim, M.D. Dubai - UAE

Nooshin Bazargani, M.D. Dubai - UAE

Ahmed Omran, M.D. Riyadh - Saudi Arabia

Salem Al Kaabi, M.D. Abu Dhabi - UAE

Fahad Baslaib, M.D. Dubai - UAE

Ghazi Ahmad Radaideh, M.D. Dubai - UAE

Wael Al Mahmeed, M.D. Abu Dhabi - UAE

Omar Hallak, M.D. Dubai - UAE

Abdullah Shehab, M.D. Al Ain - UAE

Mohamed Al-Mehairi, M.D. Al Ain - UAE

Hussein Ismaeel, M.D. Beirut - Lebanon

Hadi Skouri, M.D. Beirut - Lebanon

Safaa Almohada, M.D. Abu Dhabi - UAE

Adel Khalifa, M.D. Muharraq - Bahrain

Rakesh Suri, M.D. Abu Dhabi - UAE

Arif Al-Mulla, M.D. Abu Dhabi - UAE

Tomislav Mihaljevic, M.D. Abu Dhabi - UAE

Murat Tuzcu, M.D. Abu Dhabi - UAE

Alawi Al Sheikh-Ali, M.D. Dubai - UAE

Hani Najm, M.D Riyadh - Saudi Arabia

www.CVUAE.com

11

Industry Partners

Platinum Sponsors

NOVARTIS Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. Novartis Group companies employ approximately 135,000 full-time-equivalent associates and sell products in more than 150 countries around the world. For more information, please visit www.novartis.com

AMGEN Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

12 www.CVUAE.com

13

Industry Partners

Gold Sponsor

14 www.CVUAE.com

Industry Partners

Supporter On the 10th of April 1999, the late Sheikh Maktoum Bin Rashid Al Maktoum, UAE Vice President, and Prime Minister and Ruler of Dubai, issued the Supreme Decree No. (5) to establish the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, with the objective of honoring scientists from every part of the world who tirelessly pursue distinctive medical research that serves the larger interests of humanity. The Board of Trustees and the General Secretariat of Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences was formed on the 1st of May 1999, under the directives of H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai and Minister of Finance. Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences is one of the most outstanding awards from the GCC countries, and has consistently acted as a motivating force towards promoting medical services by honoring scientists and the distinct working parties in academic and therapeutic scopes alongside with medical and humanitarian services all over the world. The Award clearly recognizes the importance of scientific research in boosting the progress of UAE, and plays a proactive role in funding domestic health research through a pioneering program. The Award has proved to be widely successful, as it has been recognized by international observers and was testified by leading researchers vying for the award. This success reflects on the foundation’s international reputation and its high scientific credibility and level of performance.

www.CVUAE.com 15

Industry Partners

Exhibitors

ASTEMED -AL SHOMOUKH Trading ASTEMED -AL SHOMOUKH Trading For Tech. & Medical Supplies Co. is a Regional Medical Supplies Company with head office in Abu Dhabi and covering the MENA region through its direct offices in Dubai, Riyadh, Jeddah & Dammam besides a network of reputed sub-distributors.We take the responsibility to supply dedicated, unique and specialized Diagnostic and Surgical products to healthcare sectors (Cardiovascular , Interventional Cardiology, Anesthesia, O.T and Emergency Depts.) focusing on Patient Warming & Cooling Systems, POCT Blood coagulation analyzers, POCT Blood Gas Monitors, Non-Invasive Cardiac Output Monitors, Surgical Instruments, Intra-Operative Ultrasound Imaging and transit time flowmeters for coronary/vascular application, Cell savage and specialized range of surgical disposables. All are from global branded manufacturers like: Accriva Diagnostics/ITC, Cincinnati Sub-Zero, LifeHealth, Advancis Surgical, Medistim, Deltex, Landanger& Delacroix Chevalier Exclusively represented by ASTEMED.

MEDICAL INNOVATION TRADING Medical Innovation Trading L.L.C. established on January 2012 by enthusiastic and well experienced individual. The company was formed to distribute innovative and more advanced medical goods and to deliver exceptional services for healthcare consumers throughout UAE & GCC countries. With an outmost ambition the company’s main purpose is to uplift not only healthcare professionals continuous demands of advanced technologies, but to improve the lives of customers through innovations and discoveries of high quality products in healthcare field. The spirit of camaraderie motivates MIT to form with conducive Mission and Vision to assist humankind effectively and competitively.

Servier Servier is an independent French pharmaceutical research company. Its development is based on the continuous pursuit of innovation in the therapeutic areas of cardiovascular-, metabolic-, neurologic-, psychiatric-, bone- and joint diseases as well as cancer. In 2014, the company recorded a turnover of 4 billion euros. 92% of Servier drugs are consumed outside of France. 25% of turnover from Servier drugs were reinvested in Research and Development in 2014. With a strong international presence in 146 countries, Servier employs more than 21 400 people worldwide.

16 www.CVUAE.com

17

Notes

18 www.CVUAE.com

19

Acknowledgement The Organizing Committee would like to express its Gratitude to the following Supporters for their Unconditional Support to this Activity

Platinum Sponsors

Gold Sponsor

Exhibitors

Support Sponsor

Suggest Documents